Abstract
Background:
The United States (US) has experienced an opioid epidemic over the last two decades. Drug overdose deaths increased by 21% from 2015 to 2016, with two-thirds of these deaths attributed to opioid use disorder (OUD). This study assessed the psycho-social correlates associated with OUD over 2015–2018 in the US.
Methods:
This study used data collected from 171,766 (weighted = 245,838,163) eligible non-institutionalized US adults in the pooled National Survey on Drug Use and Health from 2015–2018. Survey-weighted descriptive, bivariate, and multivariable analyses were performed to assess the psycho-social correlates of OUD.
Results:
About 0.85% of the respondents reported having OUD in the past year. About one-quarter (26.3%), one-sixth (14.8%), and half (47.3%) of the respondents with OUD reported alcohol, marijuana, and nicotine dependence, respectively. One-sixth (16.7%) had a criminal justice involvement history, and almost one-third (30.8%) experienced a major depressive episode (MDE) in the past year. In multivariable analysis, ≤64 years, White race, male gender, lower educational attainment, unemployment, large metro area residence, history of alcohol, marijuana, nicotine use disorder, history of criminal justice involvement, and MDE in previous year were associated with higher odds of OUD. In contrast, being married, non-Hispanic African American, non-Hispanic Other, and Hispanic ethnicity, good physical health, private health insurance, and higher risk perception about addictive substance use were associated with lower odds of OUD.
Conclusions:
OUD is more prevalent among certain sociodemographic groups in the US. Targeted interventions focusing on young, White, unmarried, male, and uninsured/Medicaid/Medicare populations should be implemented to reduce the OUD.
Keywords: Opioid use disorder, major depressive episode, alcohol use disorder, marijuana use disorder, nicotine dependence, criminal justice involvement, USA
Introduction
Opioid, a class of drugs primarily used for managing pain, is one of the most commonly prescribed drugs in North America (Kuehn, 2007). However, opioid is safe when used for a short period and its addictive properties (producing euphoria) make these perfect drugs for misuse (National Institute of Drug Abuse (NIDA), 2020). Opioid misuse can culminate into opioid use disorder (OUD), which is a serious public health issue in the US (Volkow et al., 2014). According to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), OUD is defined on the basis of 11 diagnostic criteria for opioid dependence or abuse, which includes withdrawal, tolerance, use in dangerous situations, trouble with the law, and interference with major obligations at work, school, or home (American Psycholgical Association (APA), 1994). OUD coupled with other sedatives/hypnotics or alcohol can lead to respiratory suppression (Connery, 2015). OUD is also positively associated with alcohol and other illicit drug abuse (Ling et al., 2011).
High prevalence of OUD coupled with its negative health outcomes is one of the major public health issues in the US today (Gomes et al., 2018). Since the 1990s, prescription opioid misuse has increased almost three-fold in the US (Hall et al., 2008). In 2017, 11.4 million people misused prescription opioids and 886 thousand people used heroin, while 2.1 million people suffered from OUD in the US (HHS.gov, 2019). Studies show young and middle-aged adults are primarily affected by the opioid epidemic. The overall death rate due to OUD increased by 15.6% from 2014 to 2015, with more pronounced increases occurring among males, those aged 25–44 years, and non-Hispanic Whites (Rudd et al., 2016). OUD also imposes a huge economic burden (Florence et al., 2016). In 2016, 1,681,359 years of potential life lost in the US were attributed to OUD (Gomes et al., 2018). It also places significant burden on the health system resources and health financing (Meyer et al., 2014).
Considering the burden of OUD in the US, it is important to examine and identify the psycho-social determinants of OUD. We hypothesized that sociodemographic characteristics, for example, age, gender, race/ethnicity, education, employment, as well as psycho-social factors such as other substance use disorders and depression history in last year preceding the survey, e.g., history of alcohol and marijuana use disorder, nicotine dependence, and major depressive episode (MDE) are associated with OUD in the US. This study aimed to assess those associations. Updated findings on the psycho-social determinants of OUD will help policymakers, state health departments, healthcare practitioners and researchers identify high-risk groups for targeted OUD interventions. Since few studies exist that examine psycho-social correlates of OUD among US adult populations using nationally representative datasets in the US, this study will help to fill this research gap in the scientific literature.
Methods
Data source
This study used the pooled National Survey on Drug Use and Health (NSDUH) data from 2015–2018. The NSDUH is a nationally representative cross-sectional survey of the non-institutionalized population in the US conducted annually by the Substance Abuse and Mental Health Services Administration (SAMHSA). The NSDUH collects data on the use of alcohol, tobacco, illicit drugs and other substance use and misuse, perceived risk from substance use, mental illnesses, major depressive episodes (MDE), substance use disorders, and utilization of a variety of substance use and behavioral health treatments (SAMHSA, 2018). Detailed data collection methods, survey design and sampling, and response validity can be found elsewhere (SAMHSA, 2018).
Since this study focused on exploring the psycho-social determinants of OUD among the adult US population, the study sample included, on average, 42,942 eligible non-institutionalized US civilians aged ≥18 years each year [N = 171,766 in the 4-year period]. All estimates were weighted to account for NSDUH’s complex survey design and the nationally representative weighted pool includes 245,838,163 adults.
Dependent variable
The NSDUH was partially redesigned in 2015 to include the term “use disorder” instead of “dependence or abuse” for various substance use disorders, including OUD. Therefore, OUD was examined using the 2015–2018 data only. In 2015–2018 surveys, respondents were classified as having a past year opioid use disorder if they had either a heroin use disorder (i.e. dependence or abuse), or pain reliever use disorder related with their misuse of prescription pain relievers in the past year, or if they had both (Edwards et al., 2017). Respondents were also asked about any symptoms of OUD during the past year. OUD was operationalized using the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria for dependence (≥3 of 7) or abuse (≥1 of 4) during the 12-months preceding the survey (American Psycholgical Association (APA), 1994).
Independent variables
Survey-weighted descriptive, bivariate analyses and logistic regression, adjusting for age, gender, race/ethnicity, education, employment, residence, health insurance status, physical health status, history of criminal justice involvement, risk perception on addictive substance use, history of alcohol and marijuana use disorder, nicotine dependence, and MDE in the past year (yes, no), were performed to assess the determinants of OUD.
Based on the DSM-IV criteria (American Psycholgical Association (APA), 1994), MDE in the NSDUH was defined as a period of at least two weeks when the individual experienced a depressed mood or loss of interest or pleasure in daily activities and other additional symptoms. Alcohol and marijuana use disorder history was elicited by asking the respondents whether they had any use disorder of alcohol and/or marijuana in the past year. Nicotine dependence in past 30 days was assessed using the Nicotine Dependence Syndrome Scale (Shiffman et al., 2004). An index depicting a respondent’s perception on the risk potential of using 6 addictive substances in different frequencies (e.g. 4/5 drinks nearly daily, 5 or more drinks once or twice a week, smoking one or more pack of cigarettes daily, smoking marijuana once a month, smoking marijuana once or twice a week, trying heroin once or twice, using heroin once or twice a week, trying LSD once or twice, using LSD once or twice a week, using cocaine once a month, using cocaine once or twice a week) was created using principal component analysis. Based on the principal component score, the respondents were categorized into four groups (coded 1 = No risk, 2 = slight risk, 3 = moderate risk, 4 = great risk). We recoded respondents’ ratings of their overall health as 1 = excellent, very good, or good or 0 = fair or poor. History of criminal justice involvement in the past 12 months was generated by combining two items: the number of times the respondent “stole or tried to steal anything worth >$50.00” and “attacked someone with the intent to hurt them,” (coded 0 = none or 1 = any) (Griesler et al., 2019).
Data analysis
For descriptive statistics, we measured the frequency and percentage of respondents who had OUD in past year. Bivariate analysis was performed using the unadjusted logistic regression models with OUD as the outcome variable and other covariates as the exposure variables. Survey-weighted logistic regression model was used for multivariable analysis of factors associated with OUD in the US adult population. All analyses were performed with STATA 16.0 (StataCorp, 2019).
Results
Characteristics of the respondents and respondents with OUD compared with no OUD
About 0.85% of the respondents reported having OUD in the past year during the study period. Among respondents (weighted N = 245,838,163), the majority were female (51.8%), non-Hispanic White (64.1%), married (51.9%), full-time employed (49.4%), resided in a large metro area (55.9%), and had private health insurance (64.9%); while, 25.4% were 50–64 years old, 31.3% were college graduates or had a higher degree, and 37.6% had an annual household income of ≥$75,000 (Table 1).
Table 1.
Characteristics | Total N = 171,766 % |
Respondents with OUD* N = 1,859(0.9%) % |
Respondents with no OUD N = 169,907 (99.1%) % |
p-value |
---|---|---|---|---|
Age, in Years | <0.001 | |||
≥65 | 19.9 | 3.3 | 20.1 | |
18–25 | 14.0 | 19.2 | 13.9 | |
26–34 | 15.9 | 27.6 | 15.8 | |
35–49 | 24.8 | 27.9 | 24.7 | |
50–64 | 25.4 | 21.9 | 25.4 | |
Gender | <0.001 | |||
Female | 51.8 | 40.9 | 51.9 | |
Male | 48.2 | 59.1 | 48.1 | |
Race/Ethnicity | <0.001 | |||
Non-Hispanic White | 64.1 | 72.5 | 64.0 | |
Non-Hispanic African American | 11.8 | 10.6 | 11.9 | |
Non-Hispanic Other | 8.2 | 5.2 | 8.2 | |
Hispanic | 15.9 | 11.7 | 16.0 | |
Education | <0.001 | |||
College graduate or higher | 31.3 | 13.7 | 31.3 | |
Less than high school | 12.9 | 19.1 | 12.9 | |
High School | 25.0 | 33.2 | 25.0 | |
Some college/Associate degree | 30.9 | 34.0 | 30.9 | |
Marital status | <0.001 | |||
Never been married | 28.4 | 50.1 | 28.2 | |
Married | 51.9 | 26.7 | 52.2 | |
Widowed/separated/divorced | 19.7 | 23.2 | 19.6 | |
Employment status | <0.001 | |||
Full-time | 49.4 | 41.1 | 49.5 | |
Part-time | 13.1 | 12.7 | 13.1 | |
Unemployed | 4.4 | 13.4 | 4.3 | |
Other | 34.1 | 32.8 | 33.1 | |
Annual household income | <0.001 | |||
≥$75,000 | 37.6 | 22.8 | 37.8 | |
<$20,000 | 16.7 | 31.4 | 16.5 | |
$20,000–$49,999 | 29.7 | 32.1 | 29.7 | |
$50,000–$74,999 | 16.0 | 13.7 | 16.0 | |
Residence | 0.120 | |||
Non-metro | 14.2 | 15.6 | 14.2 | |
Large metro | 55.9 | 52.7 | 55.9 | |
Small metro | 29.9 | 31.7 | 29.9 | |
Health insurance | <0.001 | |||
Private insurance | 64.9 | 3.7 | 65.1 | |
No insurance | 9.9 | 19.2 | 9.8 | |
Medicaid/CHIP | 10.2 | 30.2 | 10.1 | |
Medicare | 7.6 | 7.3 | 7.6 | |
Tricare/CHAMPS/VA | 5.2 | 3.3 | 5.2 | |
Other | 2.2 | 3.6 | 2.2 | |
Physical health | <0.001 | |||
Bad | 13.9 | 29.7 | 13.9 | |
Good | 86.1 | 70.3 | 86.1 | |
History of criminal justice involvement | <0.001 | |||
No | 98.6 | 83.3 | 98.7 | |
Yes | 1.4 | 16.7 | 1.3 | |
Risk perception on addictive substance use | <0.001 | |||
No risk | 19.3 | 45.1 | 19.1 | |
Slight risk | 22.1 | 26.2 | 22.1 | |
Moderate risk | 26.8 | 19.4 | 26.8 | |
Great risk | 31.8 | 9.3 | 32.0 | |
Alcohol dependence/Abuse | <0.001 | |||
No | 94.1 | 73.7 | 94.2 | |
Yes | 5.9 | 26.3 | 5.8 | |
Marijuana dependence/Abuse | <0.001 | |||
No | 98.6 | 85.2 | 98.7 | |
Yes | 1.4 | 14.8 | 1.3 | |
Nicotine dependence | <0.001 | |||
No | 92.5 | 52.7 | 92.8 | |
Yes | 7.5 | 47.3 | 7.2 | |
Major depressive episode (MDE) | <0.001 | |||
No | 93.1 | 71.2 | 93.2 | |
Yes | 6.9 | 28.8 | 6.8 | |
Year | 0.230 | |||
2018 | 25.3 | 23.2 | 25.3 | |
2017 | 25.1 | 24.2 | 25.1 | |
2016 | 24.9 | 25.1 | 24.9 | |
2015 | 24.7 | 27.5 | 24.7 |
OUD: Opioid Use Disorder.
Among respondents with OUD (weighted N = 2,082,068), the majority were male (59.1%), non-Hispanic White (72.5%), never been married (50.1%), resided in a large metro area (52.7%), and insured through Medicaid/CHIP (30.2%); while, 27.9% were 35–49 years old, 41.1% had full-time employment, 34.0% were some college or associate degree holders, and 32.1% had an annual household income of $20,000–$49,999 (Table 1).
Among the respondents with no OUD, the majority were female (51.9%), non-Hispanic White (64.0%), married (52.2%), resided in a large metro area (55.9%), and had health insurance (90.3%); whereas, 25.4% were 50–64 years old, 31.3% were a college graduate or had a higher degree, 49.5% had full-time employment, 64.9% had private health insurance, and 37.8% had an annual household income of ≥$75,000.
About 26.3% of the respondents with OUD reported having alcohol dependence/abuse in the past year compared with only 5.8% of respondents without OUD; while 14.8% of the respondents with OUD reported having marijuana use disorder in the past year compared with only 1.3% of the respondents without OUD. Similarly, 45.1% of respondents with OUD perceived no risk was involved with addictive substance use, whereas, only 9.3% of those who perceived that addictive substance use poses a great risk reported having OUD. Almost half (47.3%) of the respondents with OUD had nicotine dependence, while only 7.2% of the respondents without OUD reported nicotine dependence. One-sixth (16.7%) of the respondents with OUD reported a history of criminal justice involvement in the preceding year, while only 1.3% of the respondents without OUD reported so. More than a quarter (28.8%) of the respondents with OUD had MDE in the past year compared with only 6.8% of the respondents with no OUD.
Results of bivariate analysis
In bivariate analysis, we found that respondents with a history of alcohol use disorder (Odds Ratio [OR] = 5.82, 95% Confidence Interval [CI] = 5.00–6.78) compared with no history of alcohol use disorder in the past year; a history of marijuana use disorder (OR = 13.04, 95% CI = 10.62–16.01) compared with no history of marijuana use disorder in the past year; nicotine dependence (OR = 11.64, 95% CI = 10.08–13.45) compared with no nicotine dependence in the past month; a history of criminal justice involvement (OR = 15.37, 95% CI = 13.15–17.96) compared with no history of criminal justice involvement in the past year; a history of MDE (OR = 5.58, 95% CI = 4.83–6.46) compared with no history of MDE in the preceding year had higher odds of reporting OUD (Table 2). Moreover, younger age was associated with higher odds of reporting OUD, 18–25 years (OR = 8.42, 95% CI = 4.74–14.95), 26–34 years (OR = 10.66, 95% CI = 5.96–19.01), 35–49 years (OR = 6.91, 95% CI = 3.86–12.39), 50–64 years (OR = 5.28, 95% CI = 2.92–9.53) compared with ≥65 years old. In addition, respondents who were men (OR = 1.55, 95% CI = 1.36–1.77) compared with female; had less than a high school education (OR = 3.41, 95% CI = 2.63–4.41), high school education (OR = 3.05, 95% CI = 2.32–4.01), some college/associate degree (OR = 2.52, 95% CI = 1.92–3.30) compared with college graduate or higher degree holders; unemployed (OR = 3.73, 95% CI = 3.13–4.44) compared with full-time employed; annual household income <$20,000 (OR = 3.14, 95% CI = 2.54–3.88), $20,000–$49,999 (OR = 1.79, 95% CI = 1.45–2.21), and $50,000–$74,999 (OR = 1.41, 95% CI = 1.13–1.77) compared with respondents with annual household income ≥$75,000; had no health insurance (OR = 3.50, 95% CI = 2.86–4.29), Medicaid/CHIP (OR = 5.35, 95% CI = 4.60–6.22), Medicare (OR = 1.71, 95% CI = 1.26–2.31), other health insurance (OR = 2.85, 95% CI = 1.92–4.24) compared with those who had private health insurance had higher odds of reporting OUD. Whereas, respondents who were non-Hispanic Other (OR = 0.56, 95% CI = 0.44–0.70), Hispanic (OR = 0.65, 95% CI = 0.50–0.84) compared with non-Hispanic White; married (OR = 0.29, 95% CI = 0.24–0.34), and widowed/separated/divorced (OR = 0.66, 95% CI = 0.55–0.80) compared with never-married; having good physical health (OR = 0.38, 95% CI = 0.32–0.45) compared with bad physical health; and having slight (OR = 0.50, 95% CI = 0.42–0.60), moderate (OR = 0.31, 95% CI = 0.25–0.38), great (OR = 0.12, 95% CI = 0.10–0.16) risk perception about drug dependence compared with those who perceived no-risk involved with drug dependence had lower odds of reporting OUD.
Table 2.
Characteristics | Unadjusted odds ratio | 95% CI | Adjusted odds ratio | 95% CI |
---|---|---|---|---|
Age, in Years | ||||
≥65 | 1.00 | – | 1.00 | – |
18–25 | 8.42*** | 4.74–14.95 | 2.16 | 0.99–4.69 |
26–34 | 10.66*** | 5.96–19.01 | 3.83*** | 1.86–7.85 |
35–49 | 6.91*** | 3.86–12.39 | 3.60*** | 1.82–7.11 |
50–64 | 5.28*** | 2.92–9.53 | 3.10** | 1.60–6.01 |
Gender | ||||
Female | 1.00 | – | 1.00 | – |
Male | 1.55*** | 1.36–1.77 | 1.29** | 1.11–1.48 |
Race/Ethnicity | ||||
Non-Hispanic White | 1.00 | – | 1.00 | – |
Non-Hispanic African American | 0.79 | 0.58–1.07 | 0.66* | 0.47–0.92 |
Non-Hispanic Other | 0.56*** | 0.44–0.70 | 0.60** | 0.45–0.80 |
Hispanic | 0.65** | 0.50–0.84 | 0.61** | 0.45–0.83 |
Education | ||||
College graduate or higher | 1.00 | – | 1.00 | – |
Less than high school | 3.41*** | 2.63–4.41 | 1.48** | 1.05–2.08 |
High school | 3.05*** | 2.32–4.01 | 1.50** | 1.07–2.09 |
Some college/Associate degree | 2.52*** | 1.92–3.30 | 1.43* | 1.05–1.94 |
Marital status | ||||
Never been married | 1.00 | – | 1.00 | – |
Married | 0.29*** | 0.24–0.34 | 0.67** | 0.54–0.84 |
Widowed/separated/divorced | 0.66*** | 0.55–0.80 | 0.92 | 0.72–1.17 |
Employment status | ||||
Full-time | 1.00 | – | 1.00 | – |
Part-time | 1.16 | 0.94–1.44 | 1.00 | 0.76–1.32 |
Unemployed | 3.73*** | 3.13–4.44 | 1.58*** | 1.27–1.96 |
Other | 1.19* | 01.01–1.41 | 1.15 | 0.89–1.49–1.68 |
Annual household income | ||||
≥$75,000 | 1.00 | – | 1.00 | – |
<$20,000 | 3.14*** | 2.54–3.88 | 0.98 | 0.74–1.29 |
$20,000–$49,999 | 1.79*** | 1.45–2.21 | 0.90 | 0.69–1.19 |
$50,000–$74,999 | 1.41** | 1.13–1.77 | 1.04 | 0.82–1.33 |
Residence | ||||
Non-metro | 1.00 | – | 1.00 | – |
Large metro | 0.86 | 0.73–1.02 | 1.26** | 1.06–1.50 |
Small metro | 0.97 | 0.81–1.15 | 1.12 | 0.93–1.36 |
Health insurance | ||||
Private insurance | 1.00 | – | 1.00 | – |
No insurance | 3.50*** | 2.86–4.29 | 1.62*** | 1.27–2.06 |
Medicaid/CHIP | 5.35*** | 4.60–6.22 | 2.20*** | 1.80–2.69 |
Medicare | 1.71** | 1.26–2.31 | 1.51* | 1.00–2.29 |
Tricare/CHAMPS/VA | 1.12 | 0.76–1.65 | 1.08 | 0.71–1.63 |
Other | 2.85*** | 1.92–4.24 | 1.91** | 1.20–3.05 |
Physical health | ||||
Bad | 1.00 | – | 1.00 | – |
Good | 0.38*** | 0.32–0.45 | 0.65*** | −0.52–0.82 |
History of criminal justice involvement | ||||
No | 1.00 | 1.00 | – | |
Yes | 15.37*** | 13.15–17.96 | 4.74*** | 3.84–5.85 |
Risk perception on addictive substance use | ||||
No risk | 1.00 | 1.00 | ||
Slight risk | 0.50*** | 0.42–0.60 | 0.67*** | 0.55–0.82 |
Moderate risk | 0.31*** | 0.25–0.38 | 0.57*** | 0.45–0.72 |
Great risk | 0.12*** | 0.10–0.16 | 0.33*** | 0.24–0.44 |
Alcohol dependence/Abuse | ||||
No | 1.00 | – | 1.00 | – |
Yes | 5.82*** | 5.00–6.78 | 2.06*** | 1.67–2.54 |
Marijuana dependence/Abuse | ||||
No | 1.00 | – | 1.00 | – |
Yes | 13.04 | 10.62–16.01 | 3.38*** | 2.63–4.35 |
Nicotine dependence | ||||
No | 1.00 | – | 1.00 | – |
Yes | 11.64*** | 10.08–13.45 | 4.44*** | 3.67–5.37 |
Major depressive episode (MDE) | ||||
No | 1.00 | – | 1.00 | – |
Yes | 5.58*** | 4.83–6.46 | 2.31*** | 1.88–2.85 |
Year | ||||
2018 | 1.00 | – | 1.00 | – |
2017 | 1.05 | 0.85–1.30 | 1.01 | 0.80–1.28 |
2016 | 1.10 | 0.89–1.36 | 1.09 | 0.86–1.40 |
2015 | 1.21 | 0.98–1.51 | 1.19 | 0.94–1.50 |
p-value < 0.05.
p-value < 0.01.
p-value < 0.001.
Multivariable analysis
Survey-weighted logistic regression results showed that respondents who had MDE had higher odds of having OUD compared with respondents with no MDE (adjusted Odds Ratio (aOR) = 2.31; 95% CI = 1.88–2.87) (Table 2). Respondents who had a history of alcohol use disorder were more likely to have OUD than those who had no such history (aOR = 2.06; 95% CI = 1.67–2.54). Respondents who had a history of marijuana use disorder were more likely to have OUD than those who had no such history (aOR = 3.38; 95% CI = 2.62–4.37). Respondents who used nicotine and had nicotine dependence were more likely to have OUD than those who did not have nicotine dependence (aOR = 4.44; 95% CI = 3.67–5.37). Respondents who had a history of criminal justice involvement were more likely to have OUD than those who had no such history (aOR = 4.74; 95% CI = 3.84–5.85).
Higher odds of having OUD was associated with 26–34 years (aOR = 3.83, 95% CI = 1.86–7.85), 35–49 years (aOR = 3.60, 95% CI = 1.82–7.11), 50–64 years (aOR = 3.10, 95% CI = 1.60–6.01) compared with ≥65 years old; male (aOR = 1.29; 95% CI = 1.11–1.48) compared with female; less than a high school education (aOR = 1.48, 95% CI = 1.50–2.08), high school education (aOR = 1.50, 95% CI = 1.07–2.09), some college/associate degree (aOR = 1.43, 95% CI = 1.05–1.94) compared with college or higher degree; and unemployed (aOR = 1.58, 95% CI = 1.27–1.96)compared with full-time employed; large metro residents (aOR = 1.26, 95% CI = 1.06–1.50) compared with non-metro residents; had no health insurance (aOR = 1.62, 95% CI = 1.27–2.06), Medicaid/CHIP (OR 2.20, 95% CI = 1.80–2.69), Medicare (OR = 1.51, 95% CI = 1.00–2.29), other health insurance (OR = 1.91, 95% CI = 1.20–3.05) compared with those who had private health insurance.
In contrast, lower odds of having OUD included non-Hispanic African American (aOR = 0.66, 95% CI = 0.47–0.92), non-Hispanic other (aOR = 0.60, 95% CI = 0.45–0.80), Hispanic (aOR = 0.61, 95% CI = 0.45–0.83) compared with non-Hispanic White; married (aOR = 0.67, 95% CI = 0.54–0.84) compared with never-married; having good physical health (aOR = 0.65, 95% CI = 0.52–0.82) compared with bad physical health; and having slight (aOR = 0.67, 95% CI = 0.55–0.82), moderate (aOR = 0.57, 95% CI = 0.45–0.72), or great (aOR = 0.33, 95% CI = 0.24–0.44) risk perception about addictive substance use compared with perceiving no-risk involved with addictive substance use.
Discussion
Main findings and interpretations
This study found that US adults who were younger, White, male, unemployed, had lower educational attainment, had past-year marijuana, and alcohol use disorder, past-month nicotine dependence, past-year criminal justice involvement, and had MDE in the past year were more likely to report having OUD. However, respondents who were married, non-Hispanic African American and other races, Hispanic ethnicity, and had slight, moderate or greater risk perception about using addictive substances compared with perceiving no-risk had lower odds of reporting OUD.
This study found that the respondents aged 26–64 were more likely to have OUD than older people (≥65 years old). This is in agreement with the current trend shown from NSDUH data that the uses of both non-prescription opioid (e.g. heroin) and prescription opioid (e.g. oxycontin) have been declining among teenagers (12 to 17 years) (Johnston et al., 2019), while prescription opioid use is highest among the adult population (≥26 years). Majority of those with OUD reported starting opioid misuse in their early 20 s, which may culminate into OUD later in their life (NASEM, 2017).
Another study found that non-Hispanic African American and Other races, and Hispanic populations were less likely to misuse opioids compared with non-Hispanic Whites. This trend of misuse of drugs, especially opioids, contributed to the recent decline in the life expectancy of White populations in the US (Case & Deaton, 2015). The social context and market regulation policy of the US increases the accessibility of White populations to prescription opioids, which in turn, provides an environment that can facilitate long term misuse of the drug (Hansen & Netherland, 2016).
Lower educational attainment was significantly associated with OUD. This is concordant with the findings of previous studies (Ho, 2017; Hollingsworth et al., 2017; Zhou et al., 2018). Populations with lower educational attainment tend to be involved in manual labor, which can increase the risk of workplace injury and chronic health conditions, that may increase their chances to be prescribed or use opioid medications (Bohnert et al., 2011; Ho, 2017). Further, this population may also be involved in activities like seeking opioid prescriptions from multiple physicians, to maximize their profit by selling the drugs (Ho, 2017; Keyes et al., 2014). Moreover, individuals with lower educational attainment have poor access to rehabilitation and addiction management programs, less social network support and less financial resources, that also increases their likelihood of OUD (Ho, 2017).
Similar to previous studies, this study found that a history of alcohol use disorder and/or MDE is associated with OUD (Garnier et al., 2009; Soyka, 2015). Fiellin et al. found that the progression of OUD in young adulthood follows exposure to alcohol during adolescence – known as the “gateway” model (Fiellin et al., 2013). Also, people with a history of alcohol use may experience chronic pain as a result of fights and falls, which may lead them to opioid use (Edwards et al., 2017).
In the current study, marijuana use disorder was also found to be associated with higher odds of OUD. Similarly, a prospective study that followed up more than 33,000 people and showed that marijuana use increased non-medical prescription opioid use and OUD (Olfson et al., 2018). Since heroin and tetrahydrocannabinol (THC) have similar effect on dopamine transmission through the mu opioid receptor (Tanda et al., 1997), it was found that young rats which were exposed to THC developed heroin self-administration as adults (Ellgren et al., 2007). Moreover, due to its relative availability and recent legalization in different states, marijuana can act as a gateway drug for other substance use, such as, heroin and cocaine (Hall & Lynskey, 2005).
We also found that nicotine dependence was associated with higher odds of OUD among US adults. In a prospective study conducted in Norway among 12,484 men and 15,894 women aged 30–75 years found that repeated prescription frequency of opioids was higher for men and women with a history of smoking (Skurtveit et al., 2010). One recent study showed that current smokers among young adults (18–25 years) were more likely to use/misuse prescription opioids (Romberg et al., 2019). Nicotine dependence and OUD is particularly a worse combination because smokers who have OUD may be less adherent to varenicline (medication for smoking cessation) due to the interaction between nicotine and opioid receptors (Martin et al., 2019).
The study findings showed that history of criminal justice involvement had a strong association with OUD. Crime and opioid misuse tend to occur together (Hammersley et al., 1989) and the relationship between delinquent behavior and OUD is more pronounced among adolescents and young people (Koh et al., 2017; McCauley et al., 2010). Similarly, OUD among adults also shows a positive association with the history of criminal justice involvement.
The positive association between MDE and OUD in the current study is consistent with the previous literature (Grattan et al., 2012; Smith et al., 2017; Sullivan, 2018). A review article showed that depressed patients are more likely to become chronic users of opioids. Frequent opioid overuse related to insomnia and stress has also been observed in depressed patients (Sullivan, 2018).
This study found that marriage and having good physical health lowered the odds of OUD. This finding is in agreement with findings from previous studies, which showed marriage as a protective factor against illicit drug use including OUD (Merline et al., 2004; Moos et al., 2002; Yamaguchi & Kandel, 1985). Marriage may play a role in positive treatment outcome, assessed using addiction severity index capturing last 30-days addiction to alcohol and other drugs, in individuals already suffering from OUD (Moos et al., 2002). Since the most commonly cited cause for opioid use is physical pain (Han et al., 2017), it is not surprising that good physical health condition is associated with lower chance of OUD.
In this study we explored the risk perception of six different drugs using an index, and its effects on the OUD. It is expected that the greater awareness about drug dependence would deter individuals from opioid dependence. The results show that higher perception of risk related to drug use is associated with lower odds of OUD. In a recent study, authors found a statistically significant association between lifetime heroin use and a lower likelihood of reporting great risk of trying heroin (Votaw et al., 2017). From our study we can surmise that greater risk perception about overall drug dependence may deter individuals from misusing and abusing opioids.
Strengths and limitations
There are several notable strengths of this study. The NSDUH used a large nationally representative sample and the findings of this study are generalizable to the non-institutionalized US adult population. Moreover, the surveys used standard and validated tools for data collection. In addition, pooling four-years of data increased the sample size and the power of the current study.
However, the limitations of the study warrant discussion. First, due to the cross-sectional nature of the survey, the temporal relationship cannot be established between explanatory variables and OUD. As a result, causal relationships could not be inferred. Further prospective research is warranted to elucidate the causal association between various determinants on OUD among adults. Second, due to the self-reported data of opioid use and its associated factors, there is a possibility of underreporting or overreporting, which may result in underestimates or overestimates of the “true” association. Finally, since NSDUH collect data only on prescribed fentanyl, the OUD associated with fentanyl illicitly manufactured in clandestine laboratories may not be fully captured in this analysis (SAMHSA, 2019).
Conclusions
A multifaceted approach is needed to address the several factors that have positive associations with OUD. Tailoring interventions for White populations who have higher odds of OUD compared with other racial/ethnic groups may be beneficial in reducing OUD rates. Other populations, which should be considered for OUD interventions include men, those with lower education, who are unemployed, who have had a marijuana and alcohol use disorder, nicotine dependence, criminal justice involvement and had an MDE. Targeted behavioral and educational interventions for these at-risk populations are warranted for the prevention of OUD.
Acknowledgements
The authors acknowledge the Substance Abuse and Mental Health Services Administration (SAMHSA) for use of the National Survey on Drug Use and Health (NSDUH) datasets.
Funding/support
This research was not supported by any specific research funding.
Role of the funder/sponsor
The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Funding
BO and XL are supported by National Institute of Allergy and Infectious Diseases (NIAID)-funded R01 award (Award Number R01AI127203). MJB is supported by the National Institute of Mental Health (NIMH)-funded K01 award (Award Number K01MH115794). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Footnotes
Declaration of interest
The authors report no conflicts of interest.
Data availability statement
The data that support the findings of this study are openly available in Substance Abuse & Mental health Data Archive (SMHDA) at https://www.datafiles.samhsa.gov/study-series/national-survey-drug-use-and-health-nsduh-nid13517.
References
- American Psycholgical Association (APA). (1994). Diagnostic and statistical manual of mental disorders. American Psychiatric Association (APA). [Google Scholar]
- Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, & Blow FC (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA, 305(13), 1315–1321. 10.1001/jama.2011.370 [DOI] [PubMed] [Google Scholar]
- Case A, & Deaton A (2015). Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proceedings of the National Academy of Sciences of the United States of America, 112(49), 15078–15083. 10.1073/pnas.1518393112 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Connery HS (2015). Medication-assisted treatment of opioid use disorder: Review of the evidence and future directions. Harvard Review of Psychiatry, 23(2), 63–75. 10.1097/HRP.0000000000000075 [DOI] [PubMed] [Google Scholar]
- Edwards KA, Vowles KE, & Witkiewitz K (2017). Co-use of alcohol and opioids. Current Addiction Reports, 4(2), 194–199. 10.1007/s40429-017-0147-x [DOI] [Google Scholar]
- Ellgren M, Spano SM, & Hurd YL (2007). Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats. Neuropsychopharmacology, 32(3), 607–615. 10.1038/sj.npp.1301127 [DOI] [PubMed] [Google Scholar]
- Fiellin LE, Tetrault JM, Becker WC, Fiellin DA, & Hoff RA (2013). Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults. The Journal of Adolescent Health, 52(2), 158–163. 10.1016/j.jadohealth.2012.06.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Florence C, Luo F, Xu L, & Zhou C (2016). The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Medical Care, 54(10), 901–906. 10.1097/MLR.0000000000000625 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garnier LM, Arria AM, Caldeira KM, Vincent KB, O’Grady KE, & Wish ED (2009). Nonmedical prescription analgesic use and concurrent alcohol consumption among college students. The American Journal of Drug and Alcohol Abuse, 35(5), 334–338. 10.1080/00952990903075059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gomes T, Tadrous M, Mamdani MM, Paterson JM, & Juurlink DN (2018). The burden of opioid-related mortality in the United States. JAMA Network Open, 1(2), e180217. 10.1001/jamanetworkopen.2018.0217 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grattan A, Sullivan MD, Saunders KW, Campbell CI, & Von Korff MR (2012). Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Annals of Family Medicine, 10(4), 304–311. 10.1370/afm.1371 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Griesler PC, Hu M-C, Wall MM, & Kandel DB (2019). Medical use and misuse of prescription opioids in the US adult population: 2016–2017. American Journal of Public Health, 109(9), 1258–1265. 10.2105/AJPH.2019.305162 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, Crosby AE, & Paulozzi LJ (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300(22), 2613–2620. 10.1001/jama.2008.802 [DOI] [PubMed] [Google Scholar]
- Hall WD, & Lynskey M (2005). Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug and Alcohol Review, 24(1), 39–48. 10.1080/09595230500126698 [DOI] [PubMed] [Google Scholar]
- Hammersley R, Forsyte A, Morrison V, & Davies JB (1989). The relationship between crime and opioid use. Addiction, 84(9), 1029–1043. 10.1111/j.1360-0443.1989.tb00786.x [DOI] [PubMed] [Google Scholar]
- Han B, Compton WM, Blanco C, Crane E, Lee J, & Jones CM (2017). Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Annals of Internal Medicine, 167(5), 293–301. 10.7326/M17-0865 [DOI] [PubMed] [Google Scholar]
- Hansen H, & Netherland J (2016). Is the prescription opioid epidemic a white problem? American Journal of Public Health, 106(12), 2127–2129. 10.2105/ajph.2016.303483 [DOI] [PMC free article] [PubMed] [Google Scholar]
- HHS.gov (2019). The opioids epidemic by the numbers. https://www.hhs.gov/opioids/sites/default/files/2019-09/opioids-infographic.pdf
- Ho JY (2017). The contribution of drug overdose to educational gradients in life expectancy in the United States, 1992–2011. Demography, 54(3), 1175–1202. 10.1007/s13524-017-0565-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hollingsworth A, Ruhm CJ, & Simon K (2017). Macroeconomic conditions and opioid abuse. Journal of Health Economics, 56, 222–233. 10.1016/j.jhealeco.2017.07.009 [DOI] [PubMed] [Google Scholar]
- Johnston LD, Miech RA, O’Malley PM, Bachman JG, Schulenberg JE, & Patrick ME (2019). Monitoring the future national survey results on drug use, 1975–2018: Overview, key findings on adolescent drug use. Institute for Social Research. [Google Scholar]
- Keyes KM, Cerda M, Brady JE, Havens JR, & Galea S (2014). Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health, 104(2), e52–e59. 10.2105/ajph.2013.301709 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koh P-K, Peh C-X, Cheok C, & Guo S (2017). Violence, delinquent behaviors, and drug use disorders among adolescents from an addiction-treatment sample. Journal of Child & Adolescent Substance Abuse, 26(6), 463–471. 10.1080/1067828X.2017.1354792 [DOI] [Google Scholar]
- Kuehn BM (2007). Opioid prescriptions soar: Increase in legitimate use as well as abuse. JAMA, 297(3), 249–251. 10.1001/jama.297.3.249 [DOI] [PubMed] [Google Scholar]
- Ling W, Mooney L, & Hillhouse M (2011). Prescription opioid abuse, pain and addiction: Clinical issues and implications. Drug and Alcohol Review, 30(3), 300–305. 10.1111/j.1465-3362.2010.00271.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Martin RA, Rohsenow DJ, & Tidey JW (2019). Smokers with opioid use disorder may have worse drug use outcomes after varenicline than nicotine replacement. Journal of Substance Abuse Treatment, 104, 22–27. 10.1016/j.jsat.2019.06.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- McCauley JL, Danielson CK, Amstadter AB, Ruggiero KJ, Resnick HS, Hanson RF, Smith DW, Saunders BE, & Kilpatrick DG (2010). The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 51(1), 84–93. 10.1111/j.1469-7610.2009.02134.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- Merline AC, O’Malley PM, Schulenberg JE, Bachman JG, & Johnston LD (2004). Substance use among adults 35 years of age: Prevalence, adulthood predictors, and impact of adolescent substance use. American Journal of Public Health, 94(1), 96–102. 10.2105/ajph.94.1.96 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meyer R, Patel AM, Rattana SK, Quock TP, & Mody SH (2014). Prescription opioid abuse: A literature review of the clinical and economic burden in the United States. Population Health Management, 17(6), 372–387. 10.1089/pop.2013.0098 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Moos RH, Nichol AC, & Moos BS (2002). Risk factors for symptom exacerbation among treated patients with substance use disorders. Addiction (Abingdon, England), 97(1), 75–85. 10.1046/j.1360-0443.2002.00063.x [DOI] [PubMed] [Google Scholar]
- NASEM. (2017). Pain management and the opioid epidemic: Balancing societal and individual benefits and risks of prescription opioid use (Phillips J, Ford M, & Bonnie R, Eds.). National Academies Press; (US: ). [PubMed] [Google Scholar]
- National Institute of Drug Abuse (NIDA). (2020). Opioids. https://www.drugabuse.gov/drugs-abuse/opioids#summary-of-the-issue
- Olfson M, Wall MM, Liu S-M, & Blanco C (2018). Cannabis use and risk of prescription opioid use disorder in the United States. The American Journal of Psychiatry, 175(1), 47–53. 10.1176/appi.ajp.2017.17040413 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Romberg AR, Lo EJM, Barton AA, Xiao H, Vallone DM, & Hair EC (2019). Cigarette smoking, prescription opioid use and misuse among young adults: An exploratory analysis. Preventive Medicine, 129, 105845. 10.1016/j.ypmed.2019.105845 [DOI] [PubMed] [Google Scholar]
- Rudd RA, Seth P, David F, & Scholl L (2016). Increases in drug and opioid-involved overdose deaths - United States, 2010–2015. MMWR. Morbidity and Mortality Weekly Report, 65(50–51), 1445–1452. 10.15585/mmwr.mm655051e1 [DOI] [PubMed] [Google Scholar]
- SAMHSA. (2018). 2017 National survey on drug use and health final analytic file codebook. https://samhda.s3-us-gov-west-1.amazonaws.com/s3fs-public/field-uploads-protected/studies/NSDUH-2017/NSDUH-2017-datasets/NSDUH-2017-DS0001/NSDUH-2017-DS0001-info/NSDUH-2017-DS0001-info-codebook.pdf
- SAMHSA. (2019). Key substance use and mental health indicators in the United States: Results from the 2018 national survey on drug use and health. https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf
- Shiffman S, Waters AJ, & Hickcox M (2004). The nicotine dependence syndrome scale: A multidimensional measure of nicotine dependence. Nicotine & Tobacco Research, 6(2), 327–348. 10.1080/1462220042000202481 [DOI] [PubMed] [Google Scholar]
- Skurtveit S, Furu K, Selmer R, Handal M, & Tverdal A (2010). Nicotine dependence predicts repeated use of prescribed opioids. Prospective population-based cohort study. Annals of Epidemiology, 20(12), 890–897. 10.1016/j.annepidem.2010.03.010 [DOI] [PubMed] [Google Scholar]
- Smith JA, Fuino RL, Pesis-Katz I, Cai X, Powers B, Frazer M, & Markman JD (2017). Differences in opioid prescribing in low back pain patients with and without depression: A cross-sectional study of a national sample from the United States. Pain Reports, 2(4), e606. 10.1097/pr9.0000000000000606 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Soyka M (2015). Alcohol use disorders in opioid maintenance therapy: Prevalence, clinical correlates and treatment. European Addiction Research, 21(2), 78–87. 10.1159/000363232 [DOI] [PubMed] [Google Scholar]
- StataCorp. (2019). Stata statistical software: Release 16. College Station, TX: StataCorp LLC. [Google Scholar]
- Sullivan MD (2018). Depression effects on long-term prescription opioid use, abuse, and addiction. The Clinical Journal of Pain, 34(9), 878–884. 10.1097/ajp.0000000000000603 [DOI] [PubMed] [Google Scholar]
- Tanda G, Pontieri FE, & Di Chiara G (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common m1 opioid receptor mechanism. Science (New York, N.Y.), 276(5321), 2048–2050. 10.1126/science.276.5321.2048 [DOI] [PubMed] [Google Scholar]
- Volkow ND, Frieden TR, Hyde PS, & Cha SS (2014). Medication-assisted therapies—tackling the opioid-overdose epidemic. The New England Journal of Medicine, 370(22), 2063–2066. 10.1056/NEJMp1402780 [DOI] [PubMed] [Google Scholar]
- Votaw VR, Wittenauer J, Connery HS, Weiss RD, & McHugh RK (2017). Perceived risk of heroin use among nonmedical prescription opioid users. Addictive Behaviors, 65, 218–223. 10.1016/j.addbeh.2016.08.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yamaguchi K, & Kandel DB (1985). On the resolution of role incompatibility: A life event history analysis of family roles and marijuana use. American Journal of Sociology, 90(6), 1284–1325. 10.1086/228211 [DOI] [Google Scholar]
- Zhou C, Yu NN, & Losby JL (2018). The association between local economic conditions and opioid prescriptions among disabled medicare beneficiaries. Medical Care, 56(1), 62–68. 10.1097/mlr.0000000000000841 [DOI] [PMC free article] [PubMed] [Google Scholar]